AC
TMO icon

Armistice Capital’s Thermo Fisher Scientific TMO Stock Holding History

Armistice Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45M Buy
91,491
+28,653
+46% +$15.5M 0.8% 20
2025
Q4 		$36.4M Buy
62,838
+7,822
+14% +$4.42M 0.43% 36
2025
Q3 		$26.7M Buy
55,016
+25,052
+84% +$11.7M 0.4% 40
2025
Q2 		$12.1M Buy
+29,964
New +$12.5M 0.21% 61
2025
Q1 		– Sell
-20,044
Closed -$10.4M – 284
2024
Q4 		$10.4M Sell
20,044
-12,109
-38% -$6.66M 0.14% 93
2024
Q3 		$19.9M Sell
32,153
-24,005
-43% -$14.2M 0.32% 65
2024
Q2 		$31.1M Buy
56,158
+41,182
+275% +$23.6M 0.39% 47
2024
Q1 		$8.7M Buy
+14,976
New +$8.4M 0.12% 103
2023
Q4 		– Sell
-21,000
Closed -$10.6M – 356
2023
Q3 		$10.6M Sell
21,000
-24,000
-53% -$12.8M 0.16% 84
2023
Q2 		$23.5M Buy
45,000
+3,000
+7% +$1.62M 0.34% 55
2023
Q1 		$24.2M Buy
42,000
+14,000
+50% +$7.89M 0.35% 52
2022
Q4 		$15.4M Sell
28,000
-22,000
-44% -$11.7M 0.27% 61
2022
Q3 		$25.4M Sell
50,000
-14,000
-22% -$7.83M 0.44% 50
2022
Q2 		$34.8K Buy
64,000
+19,000
+42% +$10.5M 0.61% 43
2022
Q1 		$26.6M Buy
45,000
+21,000
+88% +$12.1M 0.51% 49
2021
Q4 		$16M Sell
24,000
-36,000
-60% -$22.5M 0.26% 82
2021
Q3 		$34.3M Sell
60,000
-15,000
-20% -$8.23M 0.58% 49
2021
Q2 		$37.8M Buy
75,000
+17,000
+29% +$8.02M 0.68% 42
2021
Q1 		$26.5M Buy
58,000
+19,000
+49% +$9.07M 0.61% 45
2020
Q4 		$18.2M Buy
39,000
+23,000
+144% +$10.8M 0.62% 49
2020
Q3 		$7.06M Sell
16,000
-8,000
-33% -$3.31M 0.26% 70
2020
Q2 		$8.7M Sell
24,000
-4,000
-14% -$1.34M 0.38% 66
2020
Q1 		$7.94M Buy
+28,000
New +$8.83M 0.49% 58

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Armistice Capital's TMO Position: Q1 2026 in Review

Armistice Capital increased its Thermo Fisher Scientific (TMO) stake by 46% in Q1 2026, buying an estimated $15.5M and bringing the position to 91,491 shares worth $45M. The position accounts for 0.8% of the portfolio, ranked #20.

Armistice Capital first reported a position in TMO in Q1 2020 and has held it in 23 quarters since. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Armistice Capital held 91,491 shares of Thermo Fisher Scientific worth $45M as of Q1 2026.
  • Armistice Capital bought 28,653 Thermo Fisher Scientific shares in Q1 2026, an estimated $15.5M.
  • Thermo Fisher Scientific made up 0.8% of Armistice Capital's portfolio in Q1 2026, its #20 holding.
  • Armistice Capital first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 23 quarters since.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.